Clinical trials
Lipodystrophy, Familial Partial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 5 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire de la Réunion | 3 |
| Regeneron Pharmaceuticals | 3 |
| Akcea Therapeutics | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Abhimanyu Garg | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
| Elif Oral | 1 |
| Mayo Clinic | 1 |
| PatientCrossroads | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lipodystrophy, Familial Partial | 20 |
| Lipodystrophy | 8 |
| Diabetes Mellitus | 4 |
| Hypertriglyceridemia | 3 |
| Lipodystrophy, Congenital Generalized | 3 |
| Dyslipidemias | 2 |
| Fatty Liver | 2 |
| Insulin Resistance | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Diabetes Mellitus, Lipoatrophic | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.